Genetic insights of Cholesterol and Atherosclerosis; Complex Biology

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Asian Journal of Pharmaceutical Research

• Publication date

  2018-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5958/2231-5691.2018.00031.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of plaque formation and rupture.

  2014cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• Genetic Susceptibility to Atherosclerosis

  2012influential reference
• Genetics of atherosclerosis.

  2012cited by this paper
• Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk

  2011cited by this paper
• Mouse Genome-Wide Association and Systems Genetics Identify Asxl2 As a Regulator of Bone Mineral Density and Osteoclastogenesis

  2011cited by this paper
• Utility of genetic determinants of lipids and cardiovascular events in assessing risk

  2011cited by this paper
• Progress and challenges in translating the biology of atherosclerosis

  2011influential reference
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011cited by this paper
• Macrophages in the pathogenesis of atherosclerosis.

  2011cited by this paper
• Development of Apolipoprotein E–Deficient Mice

  2011cited by this paper
• Monocytes in atherosclerosis: subsets and functions

  2010cited by this paper
• Sequencing technologies — the next generation

  2010cited by this paper
• Therapeutic targeting of chemokine interactions in atherosclerosis

  2010cited by this paper
• Toward metabolomic signatures of cardiovascular disease.

  2010cited by this paper
• Genetic Modifier Loci Linked to Intima Formation Induced by Low Flow in the Mouse Carotid

  2009cited by this paper
• Lipid lowering and ischaemic heart disease.

  2009cited by this paper
• Inflammation in atherosclerosis: from pathophysiology to practice.

  2009influential reference
• Contribution of Macromolecular Structure to the Retention of Low-Density Lipoprotein at Arterial Branch Points

  2008cited by this paper
• Genetic Variation and Atherosclerosis

  2008cited by this paper
• Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

  2007cited by this paper
• Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group

  2007cited by this paper
• Genetic and genomic insights into the molecular basis of atherosclerosis.

  2007influential reference
• Beta‐sitosterolaemia: a new nonsense mutation in the ABCG5 gene

  2007cited by this paper
• T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease.

  2006cited by this paper
• Molecular regulation of HDL metabolism and function: implications for novel therapies.

  2006cited by this paper
• A molecular mechanism for the differential regulation of TGF-β1 expression due to the common SNP −509C-T (c. −1347C > T)

  2006cited by this paper
• Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr−/− and ApoE−/− Mice Transplanted With Abcg1−/− Bone Marrow

  2006cited by this paper
• Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17

  2006cited by this paper
• The immune response in atherosclerosis: a double-edged sword

  2006cited by this paper
• ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.

  2005influential reference
• Reverse cholesterol transport and cholesterol efflux in atherosclerosis.

  2005cited by this paper
• Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans

  2005cited by this paper
• Composition and classification of human atherosclerotic lesions

  2005cited by this paper
• Thematic review series : The Pathogenesis of Atherosclerosis An interpretive history of the cholesterol controversy , part IV : The 1984 Coronary Primary Prevention Trial ends it — almost 1

  2005cited by this paper
• What makes a good genetic association study?

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Genetics of variation in HDL cholesterol in humans and mice.

  2004cited by this paper
• Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways

  2004cited by this paper
• The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

  2004cited by this paper
• Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro

  2004cited by this paper
• Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis.

  2004cited by this paper
• The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man

  2004cited by this paper
• Genetic Basis of Atherosclerosis: Part II: Clinical Implications

  2004cited by this paper
• Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.

  2004cited by this paper
• Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome

  2003cited by this paper
• Genetics of gene expression surveyed in maize, mouse and man

  2003cited by this paper
• Meta-Analysis of 4 Coronary Heart Disease Genome-Wide Linkage Studies Confirms a Susceptibility Locus on Chromosome 3q

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Cholesterol, coronary heart disease and stroke in the Asia-Pacific region

  2003cited by this paper
• Apolipoprotein E Polymorphism and Atherosclerosis

  2003cited by this paper
• Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

  2003cited by this paper
• Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues

  2002cited by this paper
• Arachidonate 5-lipoxygenase.

  2002cited by this paper
• Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

  2002cited by this paper
• Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice

  2002cited by this paper
• A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

  2001cited by this paper
• A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

  2001cited by this paper
• Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age

  2001cited by this paper
• Genetics of cardiovascular disease.

  2000cited by this paper
• Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

  2000cited by this paper
• Dietary cholesterol and atherosclerosis.

  2000cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders?

  1998cited by this paper
• A family of human receptors structurally related to Drosophila Toll.

  1998cited by this paper
• Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension

  1998cited by this paper
• Dietary fat intake and the risk of coronary heart disease in women.

  1998cited by this paper
• Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36*

  1997cited by this paper
• Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells.

  1997cited by this paper
• Genetic dissection of complex traits

  1996cited by this paper
• A comprehensive genetic map of the human genome based on 5,264 microsatellites

  1996cited by this paper
• Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States

  1996cited by this paper
• The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*)

  1995cited by this paper
• A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1994cited by this paper
• A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

  1994cited by this paper
• Genetic susceptibility to death from coronary heart disease in a study of twins.

  1994cited by this paper
• Cloning of two novel ABC transporters mapping on human chromosome 9.

  1994cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary disease in women.

  1993cited by this paper
• Report of the expert panel on population strategies for blood cholesterol reduction

  1992cited by this paper
• Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12.

  1992cited by this paper
• National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health.

  1991cited by this paper
• The role of cholesterol oxidation products in the pathogenesis of atherosclerosis.

  1989cited by this paper
• Biology of cholesterol, lipoproteins and atherosclerosis.

  1989influential reference
• A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction.

  1989cited by this paper
• Clinical Significance of Hypertriglyceridemia

  1988influential reference
• The Asia-Pacific Region

  1988cited by this paper
• Lowering cholesterol, 1988. Rationale, mechanisms, and means.

  1988cited by this paper
• Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

  1987cited by this paper
• Chromosomal localization of the human apolipoprotein B gene and detection of homologous RNA in monkey intestine.

  1986cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit.

  1986cited by this paper
• Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes.

  1985cited by this paper
• Pathogenesis of atherosclerosis.

  1985cited by this paper
• Interpreting multiple logistic regression coefficients in prospective observational studies.

  1984influential reference
• Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

  1984cited by this paper
• George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components.

  1981cited by this paper
• Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.

  1981cited by this paper
• Levels and Interrelationships of Serum and Lipoprotein Cholesterol and Triglycerides

  1981cited by this paper

• Assessment of Prescribing Pattern of Cardiovascular Drugs: A Prospective Observational Study

  2025cites this paper
• Influence of Rhizophora apiculata barks extract on Cholesterol, Triglyceride, LDL, and HDL Levels of Rattus norvegicus (Sprague Dawley) fed high-cholesterol diet

  2024cites this paper
• A Review on Pharmacological and Non-Pharmacological Therapy for the treatment of Obesity with Cardiovascular Diseases

  2024cites this paper
• Statin-induced Rhabdomyolysis and its Management – A Case Report

  2024cites this paper
• Lipoprotein, Cholesterol, Treatment Strategies, and its Impact on Cardiovascular Diseases

  2024cites this paper
• Small dense LDL (sd-LDL), one of the parameters for preventing atherosclerosis risk factors in modified alternate-day fasting (MADF) perpetrator

  2023cites this paper
• Role and Responsibility of Allicin for the Prevention of Cardiovascular Diseases: A Systematic Review

  2023cites this paper
• TG/HDL, Non-HDL, and TyG index as predictive parameters for CVDs in uncontrolled diabetic patients better than LDL-C and LDL/HDL ratio

  2022cites this paper
• Lipid Lowering Effects of Herbal Supplements: A Review

  2022cites this paper